From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Loading Events

« All Events

  • This event has passed.

13th Vaccine Congress

September 15, 2019 - September 18, 2019

Organizers from Elsevier’s journal Vaccine will host the 13th Vaccine Congress 15-18 September 2019 in Bangkok, Thailand.

The congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field.

Agenda topics of interest highlighted by the Global Biodefense staff include:

  • Insertion-responsive microneedles for rapid intradermal delivery of influenza vaccine
  • Immunogenicity of virus-like particle (VLP)-based coronavirus vaccines
  • A brief review of adversomics: understanding genetic drivers for adverse events after vaccination
  • Developing a novel, safe and effective platform for generating flavivirus vaccines
  • Novel adenoviral vector platform for developing a universal influenza vaccine
  • Chicken IFITM knockout technology for increased vaccine production
  • The role of the microbiome in host interactions and vaccine responses
  • Optimized recombinant Newcastle disease virus expressing the F protein of respiratory syncytial virus has improved antigen expression levels and immunogenicity
  • Identification of immunostimulatory domains of flagellin for better adjuvant design
  • Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
  • Development of bat stem cell lines by somatic reprogramming to study bat-derived
    highly pathogenic viruses
  • Vaccination with 1/6th standard dose of a split inactivated influenza vaccine using the Nanopatch™
    induces comparable immune responses to conventional full-dose intramuscular injection
  • Mucosal immunity in therapeutic and prophylactic vaccine trials
  • Translating the intestinal microbiome for oral vaccine performance
  • Neuraminidase-based influenza virus vaccines
  • Assessment of outer membrane vesicles derived from Escherichia coli Nissle 1917as a novel mucosal adjuvant in intranasal inactivated influenza vaccine
  • Enhancing Chikungunya Virus Immunity By Improved Vaccination
  • Pre-clinical protective efficacy of a VLP-based vaccine against Zika virus
  • Needle Adapters and Needle-free Injectors for Intradermal Administration of Fractional Dose of
    Inactivated Poliovirus Vaccine

Please visit the 13th Vaccine Congress website for more information and to register for the event.

From Our Partners

Details

Start:
September 15, 2019
End:
September 18, 2019
Event Category:
Website:
http://bit.ly/13th-vaccine-congress

Organizer

Elsevier
View Organizer Website

Venue

Avani Riverside Hotel
257 Charoennakorn Road
Thonburi, Bangkok 10600 Thailand
Phone:
+66 2431 9100
View Venue Website